← feed

Is NCT04039958 results overdue?

Yes — results are overdue. Primary completion was 2017-05-13; the FDAAA-801 reporting deadline (2018-05-13) passed 2961 days ago and no results are posted on ClinicalTrials.gov.

A Study of Sofosbuvir and Ledipasvir From Soviredia 90/400 mg Tablets (Minapharm, Egypt) Versus Harvoni 90/400 mg Tablets (Gilead Sciences, USA)

NCT IDNCT04039958 ↗
SponsorGenuine Research Center, Egypt (INDUSTRY)
PhasePHASE1
StatusCOMPLETED
Primary completion2017-05-13 (ACTUAL)
Reporting deadline2018-05-13 (completion + 365d)
Days overdue2961
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 ba7c02ce7d7c0d05… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT04039958. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →